中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
6期
1078-1081
,共4页
萨仁高娃%布林白乙拉%陈继铭
薩仁高娃%佈林白乙拉%陳繼銘
살인고왜%포림백을랍%진계명
蒙药广枣%人脐血干细胞%粗提取物%细胞增殖%细胞分化
矇藥廣棘%人臍血榦細胞%粗提取物%細胞增殖%細胞分化
몽약엄조%인제혈간세포%조제취물%세포증식%세포분화
背景:目前,人脐血干细胞在脊髓损伤治疗中的研究较多,但人脐血干细胞的体外分化由许多因素所限制.蒙药广枣提取物对神经细胞有保护作用,但其作用机制不清楚.目的:观察蒙药广枣3种粗提取物促进人脐血干细胞体外分化的影响.方法:获取临床健康产妇的新鲜脐带血,制备人脐血干细胞悬液,将纯化的人脐血干细胞接种于40个培养皿中进行传代,根据蒙药广枣3种粗提取物分为:样品1组:乙醇提取,醋酸乙酯萃取,生药质量浓度为8.25 g/mL;样品2组:乙醇提取,NKA树脂分离,体积分数为10%乙醇淋洗浓缩,生药质量浓度为1.72 g/mL;样品3组:乙醇提取,NKA树脂分离,体积分数为70%乙醇淋洗浓缩,生药质量浓度为2.41 g/mL;对照组:用80%的DMEM,含体积分数为20%的小牛血清培养.观察不同质量浓度蒙药广枣提取物对人脐血干细胞增殖的影响;24,72 h后流式细胞仪测定S期的比例.结果与结论:样品3组人脐血干细胞的增殖作用不明显,10 d时样品1组和样品2组明显高于样品3组和对照组(P < 0.01).样品1组和样品2组的人脐血干细胞在24,72 h后处于S期的明显增多.提示生药质量浓度8.25,1.72 g/mL蒙药广枣粗提取物能促进人脐血干细胞的体外增殖.
揹景:目前,人臍血榦細胞在脊髓損傷治療中的研究較多,但人臍血榦細胞的體外分化由許多因素所限製.矇藥廣棘提取物對神經細胞有保護作用,但其作用機製不清楚.目的:觀察矇藥廣棘3種粗提取物促進人臍血榦細胞體外分化的影響.方法:穫取臨床健康產婦的新鮮臍帶血,製備人臍血榦細胞懸液,將純化的人臍血榦細胞接種于40箇培養皿中進行傳代,根據矇藥廣棘3種粗提取物分為:樣品1組:乙醇提取,醋痠乙酯萃取,生藥質量濃度為8.25 g/mL;樣品2組:乙醇提取,NKA樹脂分離,體積分數為10%乙醇淋洗濃縮,生藥質量濃度為1.72 g/mL;樣品3組:乙醇提取,NKA樹脂分離,體積分數為70%乙醇淋洗濃縮,生藥質量濃度為2.41 g/mL;對照組:用80%的DMEM,含體積分數為20%的小牛血清培養.觀察不同質量濃度矇藥廣棘提取物對人臍血榦細胞增殖的影響;24,72 h後流式細胞儀測定S期的比例.結果與結論:樣品3組人臍血榦細胞的增殖作用不明顯,10 d時樣品1組和樣品2組明顯高于樣品3組和對照組(P < 0.01).樣品1組和樣品2組的人臍血榦細胞在24,72 h後處于S期的明顯增多.提示生藥質量濃度8.25,1.72 g/mL矇藥廣棘粗提取物能促進人臍血榦細胞的體外增殖.
배경:목전,인제혈간세포재척수손상치료중적연구교다,단인제혈간세포적체외분화유허다인소소한제.몽약엄조제취물대신경세포유보호작용,단기작용궤제불청초.목적:관찰몽약엄조3충조제취물촉진인제혈간세포체외분화적영향.방법:획취림상건강산부적신선제대혈,제비인제혈간세포현액,장순화적인제혈간세포접충우40개배양명중진행전대,근거몽약엄조3충조제취물분위:양품1조:을순제취,작산을지췌취,생약질량농도위8.25 g/mL;양품2조:을순제취,NKA수지분리,체적분수위10%을순림세농축,생약질량농도위1.72 g/mL;양품3조:을순제취,NKA수지분리,체적분수위70%을순림세농축,생약질량농도위2.41 g/mL;대조조:용80%적DMEM,함체적분수위20%적소우혈청배양.관찰불동질량농도몽약엄조제취물대인제혈간세포증식적영향;24,72 h후류식세포의측정S기적비례.결과여결론:양품3조인제혈간세포적증식작용불명현,10 d시양품1조화양품2조명현고우양품3조화대조조(P < 0.01).양품1조화양품2조적인제혈간세포재24,72 h후처우S기적명현증다.제시생약질량농도8.25,1.72 g/mL몽약엄조조제취물능촉진인제혈간세포적체외증식.
BACKGROUND: Human umbilical cord blood stem cells have been widely used in the study of spinal cord injury, but in vitro differentiation of human umbilical cord blood stem cells (hUCBSCs) has been limited by various factors. Mongalian medicine axillary choerospondias fruit extract has protective effects on neural cells, but the action mechanisms are unclear. OBJECTIVE: To observe promoting effects of 3 kinds of Mongalian medicine axillary choerospondias fruit extracts on in vitro differentiation of hUCBSCs. METHODS: Fresh umbilical cord blood was obtained from healthy puerperants to prepare hUCBSC suspension. The purified hUCBSCs were incubated in 40 petri dishes. The Mongalian medicine axillary choerospondias fruit extracts were divided into: sample 1 group: ethanol extraction, ethyl acetate extraction, crude drug mass concentration was 8.25 g/mL; sample 2 group: ethanol extraction, NKA resin isolation, 10% ethanol eluting concentration, crude drug mass concentration was 1.72 g/mL; sample 3 group: ethanol extraction, NKA resin isolation, 70% ethanol eluting concentration, crude drug mass concentration was 2.41 g/mL; control group: incubation of 80% DMEM containing 20% calf serum. Effects of various mass concentrations of Mongalian medicine axillary choerospondias fruit extract on hUCBSCs proliferation were observed. Proportion in S phase was measured using flow cytometry at 24 and 72 hours. RESULTS AND CONCLUSION: The proliferation of hUCBSCs was not significant in the sample 3 group. At day 10, the proliferation was significantly greater in the sample 1 and 2 groups compared with the sample 3 and control groups (P < 0.01). The number of hUCBSCs was significantly increased at 24 and 72 hours in S phase in the sample 1 and 2 groups. Mongalian medicine axillary choerospondias fruit extract (crude drug mass concentration 8.25, 1.72 g/mL) could promote in vitro proliferation of hUCBSCs.